{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:42:28Z","timestamp":1760240548325,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.avsg.2022.07.022","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T23:06:57Z","timestamp":1661296017000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Association of Renin-Angiotensin-Aldosterone System Inhibitor Usage Patterns with Midterm Amputation-Free Survival after Lower Extremity Bypass for Peripheral Arterial Disease"],"prefix":"10.1016","volume":"88","author":[{"given":"Isaac N.","family":"Naazie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isibor","family":"Arhuidese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad S.","family":"Abdelgawwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Unkart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud B.","family":"Malas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2022.07.022_bib1","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.07.022_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2022.07.022_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: national health and nutrition examination study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2022.07.022_bib4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.112.108787","article-title":"Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains","volume":"126","author":"Subherwal","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2022.07.022_bib5","doi-asserted-by":"crossref","first-page":"e000697","DOI":"10.1161\/JAHA.113.000697","article-title":"Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease","volume":"3","author":"Armstrong","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2022.07.022_bib6","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jvs.2013.03.050","article-title":"Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia","volume":"58","author":"Chung","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.07.022_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/VHRM.S15484","article-title":"ACE up the sleeve - are vascular patients medically optimized?","volume":"7","author":"Coveney","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.avsg.2022.07.022_bib8","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2005.09.074","article-title":"Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease","volume":"47","author":"Feringa","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2022.07.022_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/VHRM.S137698","article-title":"Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization","volume":"13","author":"Kray","year":"2017","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.avsg.2022.07.022_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/106002809302700617","article-title":"Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction","volume":"27","author":"Beckwith","year":"1993","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.avsg.2022.07.022_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting\u2013enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2022.07.022_bib12","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.amjcard.2020.03.022","article-title":"Relation of plasma renin activity to subclinical peripheral and coronary artery disease (from the multiethnic study of atherosclerosis)","volume":"125","author":"Unkart","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.avsg.2022.07.022_bib13","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jvs.2012.03.016","article-title":"The society for vascular surgery vascular quality initiative","volume":"55","author":"Cronenwett","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.07.022_bib14","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.arth.2019.01.063","article-title":"Creation and validation of linkage between orthopedic registry and administrative data using indirect identifiers","volume":"34","author":"Mao","year":"2019","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.avsg.2022.07.022_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0002-9343(01)01001-4","article-title":"Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease","volume":"112","author":"Halkin","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.avsg.2022.07.022_bib16","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease: the Task Force on ACE-inhibitors of the European Society of Cardiology","volume":"25","author":"L\u00f3pez-Send\u00f3n","year":"2004","journal-title":"Euro Heart J"},{"key":"10.1016\/j.avsg.2022.07.022_bib17","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1093\/eurheartj\/sum037","article-title":"Angiotensin-converting enzyme inhibition: a landmark advance in treatment for cardiovascular diseases","volume":"9E","author":"Borer","year":"2007","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.avsg.2022.07.022_bib18","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive Summary: a report of the American college of cardiology\/American Heart Association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2022.07.022_bib19","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","author":"Furberg","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.avsg.2022.07.022_bib20","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.avsg.2022.07.022_bib21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jvs.2017.07.130","article-title":"Long-term mortality benefit of renin-angiotensin system inhibitors in patients with chronic limb-threatening ischemia undergoing vascular intervention","volume":"67","author":"Bodewes","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2022.07.022_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","article-title":"Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac SurgeryAn analysis of the vascular events in noncardiac surgery patIents cOhort evaluatioN prospective cohort","volume":"126","author":"Roshanov","year":"2017","journal-title":"Anesthesiology"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509622004915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509622004915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:07:37Z","timestamp":1760188057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509622004915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":22,"alternative-id":["S0890509622004915"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2022.07.022","relation":{},"ISSN":["0890-5096"],"issn-type":[{"type":"print","value":"0890-5096"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Renin-Angiotensin-Aldosterone System Inhibitor Usage Patterns with Midterm Amputation-Free Survival after Lower Extremity Bypass for Peripheral Arterial Disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2022.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}